The United States Market for In Vitro Diagnostic Tests

Mar 18, 2014
130 Pages - Pub ID: KLI5217921
Abstract Table of Contents Related Reports

The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market.  Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments for clinical testing. 

In this report, The United States Market for In Vitro Diagnostic Tests, Kalorama Information analyst Emil Salazar takes a considered look into these trends and what they mean for diagnostic manufacturers and investors. 

As the report notes, there are both challenging developments and postiive trends which make the United States a stable IVD market: The expansion of the insured population under the ACA; demographic aging that increases demand for clinical testing and a medical program that serves as a leading, stable vehicle for payment (Medicare); relatively optimistic macroeconomic indicators vis-à-vis the domestic outlook five years ago or other developed markets in the world; and continued product innovation and industry responsiveness to clients’ needs in the world’s largest IVD market. 

This report includes important tools for business planners, including market size estimates and forecasts for the following IVD segments:
  • Point of Care  (Glucose, Professional, OTC)
  • Histology and Cytology 
  • Clinical Chemistry 
  • Immunoassays (Infectious Disease, Non-Infectious Disease)
  • Molecular Assays (Non-Infectious Disease)
  • Hematology
  • Urinalysis
  • Flow Cytometry
  • Coagulation 
  • Microbiology and Virology (ID/AST, Molecular)
  • Blood Testing
Market sizes, forecasts and shares are provided, as well as a geographic breakdown of the segments, where possible. Changes in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Current market numbers are presented for 2011, with projections given through 2016. The following data points are included in this report:

  • U.S. Health Expenditure
  • U.S. Clinical Lab Expenditure
  • U.S. Infectious Disease Market Opportunities
  • Affordable Care Act (ACA)
  • Clinical Testing under Medicare – Reimbursement Cuts and “Revaluation”
  • Molecular Diagnostics and Medicare Policy
  • Patient Population
  • Healthcare System Utilization
  • Aging
  • Disease Prevalence and Incidence
  • Analyst Conclusions About the Market
Many of the top IVD companies use Kalorama Information products for business planning, which means that this volume can provide a uniform standard for in vitro diagnostic market numbers. This edition greatly expands coverage of the field and tracks the most important developments. See aspects of the industry that might not be available in your company's internal resources. View the market from an independent point of view. Learn about competitors in away that may be invisible to internal personnel. Know the market players - your competitors and potential partners, in proper context and classification. Save countless hours of staff time and other research expenses with the authoritative guide for IVD market estimates and forecasts.

As part of the reports, the following companies are covered:

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter
  • Becton Dickinson
  • Danaher Corporation
  • Hologic
  • Ortho-Clinical Diagnostics / J&J Diabetes Care
  • QIAGEN
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific

Related Reports:

Physician Office Laboratory Markets, 3rd Edition
Aug 15, 2014 - KLI5314670 - $3,995.00

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition
Aug 13, 2014 - KLI5309370 - $6,800.00

The World Market for Flow Cytometry in IVD Applications
Jun 16, 2014 - KLI5271977 - $1,995.00

Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments
May 7, 2014 - KLI5239832 - $4,500.00

Retail Clinics Market Overview and 2014 Survey Results
Mar 11, 2014 - KLI5215143 - $750.00

The Market and Potential for Molecular Point of Care Diagnostics
Feb 5, 2014 - KLI5201690 - $3,995.00

IVD in Singapore and Malaysia
Jan 1, 2014 - KLI5177833 - $1,995.00

The World Market for Hematology
Nov 22, 2013 - KLI5156915 - $3,995.00

Reimbursement for IVD Tests
Oct 25, 2013 - KLI5141105 - $1,995.00

The World Market for Infectious Disease Diagnostic Tests
Oct 21, 2013 - KLI5137619 - $3,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >

Most Popular Research
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 9th Edition
Results of The 2012 Kalorama IVD Procedure Count: White Paper
The World Market for Point of Care (POC) Diagnostics
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)
IVD Procedure Volume and Pricing Analysis
The United States Market for In Vitro Diagnostic Tests
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Home About Us My Account Personal Library Contact Us
Copyright © 2014 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
9/15/2014 - 42
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: Monday - Thursday: 5:30am - 6:30pm EST
Fridays: 5:30am - 5:30pm EST